ESC 365 - Clinical outcome in morbidity and mortality in patients with severe residual mitral regurgitation treated with MitraClip after non-response to cardiac resynchronization therapy.

ESC Premium Access

Clinical outcome in morbidity and mortality in patients with severe residual mitral regurgitation treated with MitraClip after non-response to cardiac resynchronization therapy.

Session: Improving prognosis with CRT

Topic: Resynchronisation therapy

Speaker: Doctor F. Regoli (Lugano, CH)

Event: ESC Congress 2017

Congress Presentation

Add to my library

About the speaker

Doctor Francois Diederik Regoli

Cardiocentro Ticino Foundation, Lugano (Switzerland)

0 follower

4 more presentations in this session

State of the Art: cardiac resynchronisation therapy

Speaker: Professor C. Leclercq (Rennes, FR)

Left ventricular mechanical dispersion after cardiac resynchronisation therapy: prognostic implications

Speaker: Doctor P. Van Der Bijl (Cape Town, ZA)

Scar characterization to predict life-threatening arrhythmic events and sudden cardiac death in cardiac resynchronization therapy patients.

Speaker: Doctor J. Acosta Martinez (Seville, ES)

The future in CRT, what improvements can be made?

Speaker: Professor H. Klein (Rochester, US)

Access the full session

Improving prognosis with CRT

Speakers: Doctor F. Regoli, Professor C. Leclercq, Doctor P. Van Der Bijl, Doctor J. Acosta Martinez, Professor H. Klein

About the event

ESC Congress 2017

26 August - 30 August 2017

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources